By Kim Richters

Germany's Merck KGaA (MRK.XE) said on Thursday that it acquired U.S. company FloDesign Sonics.

FloDesign Sonics provides technology that enables the manipulation of cells with ultrasonic waves and that is used in cell and gene therapy manufacturing, pharmaceutical company Merck said.

The "acquisition is a strategic fit for Merck, strengthening the ability alongside pharmaceutical manufacturers to advance cell-based therapies to patients," the company said.

The company didn't comment on the financial details of the deal.

Write to Kim Richters at kim.richters@wsj.com

(END) Dow Jones Newswires

October 10, 2019 09:47 ET (13:47 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
Merck KGaA (PK) (USOTC:MKKGY)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Merck KGaA (PK) Charts.
Merck KGaA (PK) (USOTC:MKKGY)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Merck KGaA (PK) Charts.